Research and Development

Another 150 jobs are to go at Dendreon Corporation as the company seeks to cut $125 million per year in …

The ABPI has appointed Andrew Hollingsworth as its new Policy manager who will take up the position on 25 November. …

The Amgen Foundation has announced $2.5 million in new grants for its science programme to aid schools in the US …

Eisai has become the latest pharma firm to partner with the US-based Broad Institute to pool expertise and come up …

Biopharma firm Celgene has announced the appointment of Dr Adrian Kilcoyne as its new medical director. He will take up …

An oncology database – said to be the world’s largest in any disease area and funded by Cancer Research UK …

An FDA committee has dashed hopes of an approval for Sanofi’s multiple sclerosis drug after saying its benefits may not …

Few things in my professional life have troubled me more than the Cancer Drugs Fund (CDF) since its inception in …

The International Diabetes Federation (IDF) has appointed Dr Petra Wilson as its chief executive. Wilson joins IDF from Cisco, where …

Biopharma firm Genticel has appointed Dr Gerald Moeller to sit on its supervisory Board as a vice president. Moeller has …

Alzheimer’s drugs cost three times the industry average to produce, according to a new draft report – and the way …

Rumours are growing that Shire will be cutting dozens of research posts at its R&D centre in Basingstoke, Hampshire. This …

Clinical trials services firm Biotec Services International is expanding its presence in the US and the UK with three new …

The Biotechnology and Biological Science Research Council (BBSRC) has put up £10 million which can be accessed by small companies …

Roche subsidiary ImmunoGen has abandoned a Phase II trial into small-cell lung cancer (SCLC) after deciding that it was not …